Concepedia

Rongqiang Liu

RL

Statistics

Publications

16

Citations

458

H-Index

12

Active since

2006

Affiliations

Third Affiliated Hospital of Sun Yat-sen University(Current)

Sun Yat-sen University

Guangzhou Medical University

First Affiliated Hospital of Guangzhou Medical University

Chongqing University

Rongqiang Liu is an author at Third Affiliated Hospital of Sun Yat-sen University specializing in medicine, oncology, and hepatocellular carcinoma.

ORCID

Publications per year

2006–2024

16

Publications

16

Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1–Positive Recurrent or Metastatic Cervical Cancer: A Multicenter, Single-Arm, Prospective Phase II Trial

Qin Xu, Junjie Wang, Yang Sun et al. · Journal of Clinical Oncology · 2022 · 145 citations · Full text

, , +17

A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors

Hui Fang, Shuyan Sheng, Bangjie Chen et al. · Frontiers in Immunology · 2022 · 50 citations · Full text

, , +17

The Combination of CA125 and NSE Is Useful for Predicting Liver Metastasis of Lung Cancer

Chu-Feng Wang, Shengjia Peng, Rongqiang Liu et al. · Disease Markers · 2020 · 39 citations · Full text

, , +17

Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study

Hui Li, Rongqiang Liu, Haizhou Qiu et al. · Frontiers in Oncology · 2022 · 36 citations · Full text

, , +17

Imidazolylpyrimidine based CXCR2 chemokine receptor antagonists

Koc-Kan Ho, Douglas S. Auld, Adolph C. Bohnstedt et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 27 citations · Full text

, , +12

1–5 of 16